Targeting autophagy in cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28751651.
- Also identified by DOI 10.1038/nrc.2017.53 and PMC identifier 5975367.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autophagy is a mechanism by which cellular material is delivered to lysosomes for degradation, leading to the basal turnover of cell components and providing energy and macromolecular precursors. Autophagy has opposing, context-dependent roles in cancer, and interventions to both stimulate and inhibit autophagy have been proposed as cancer therapies. This has led to the therapeutic targeting of autophagy in cancer to be sometimes viewed as controversial. In this Review, we suggest a way forwards for the effective targeting of autophagy by understanding the context-dependent roles of autophagy and by capitalizing on modern approaches to clinical trial design.
Medical subject headings
- Autophagy
- Chloroquine
- Hydroxychloroquine
- Neoplasms